Cuprina Holdings (Cayman) - Public Comps and Valuation Multiples

Cuprina Holdings (Cayman) Overview

About Cuprina Holdings (Cayman)

Cuprina Holdings (Cayman) Ltd is a biomedical and biotechnology company that is dedicated to the development and commercialization of products for the management of chronic wounds, as well as operating in the health and beauty sector. It manufactured and distributed a line of medical grade sterile blowfly larvae bio-dressing products marketed under the MEDIFLY brand name, or the MEDIFLY products. The MEDIFLY products are used as a biological debridement tool for chronic wounds, in a procedure known as Maggot Debridement Therapy, or MDT, which is an effective alternative to surgical debridement.

Founded

2023

HQ

Employees

Website

cuprina.com.sg

Sectors

Medical Supplies

Financials

Last FY Revenue $48K

Last FY EBITDA -$1.4M

EV

$168M

Valuation Multiples

Multiples.vc

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Cuprina Holdings (Cayman) Financials

In the most recent fiscal year, Cuprina Holdings (Cayman) achieved revenue of $48K and an EBITDA of -$1.4M.

Cuprina Holdings (Cayman) expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Cuprina Holdings (Cayman) valuation multiples based on analyst estimates

Cuprina Holdings (Cayman) P&L

	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	XXX	$48K	XXX	XXX	XXX
Gross Profit	XXX	-$3K	XXX	XXX	XXX
Gross Margin	XXX	-6%	XXX	XXX	XXX
EBITDA	XXX	-$1.4M	XXX	XXX	XXX
EBITDA Margin	XXX	-2958%	XXX	XXX	XXX
EBIT	XXX	-$1.5M	XXX	XXX	XXX
EBIT Margin	XXX	-3066%	XXX	XXX	XXX
Net Profit	XXX	-$1.6M	XXX	XXX	XXX
Net Margin	XXX	-3230%	XXX	XXX	XXX
Net Debt	XXX	$0.1M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

Cuprina Holdings (Cayman) Stock Performance

As of July 31, 2025, Cuprina Holdings (Cayman)'s stock price is $23.

Cuprina Holdings (Cayman) has current market cap of $168M, and EV of $168M.

See Cuprina Holdings (Cayman) trading valuation data

Cuprina Holdings (Cayman) Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$168M	$168M	XXX	XXX	XXX	XXX	n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Cuprina Holdings (Cayman) Valuation Multiples

As of July 31, 2025, Cuprina Holdings (Cayman) has market cap of $168M and EV of $168M.

Cuprina Holdings (Cayman)'s trades at 3478.0x EV/Revenue multiple, and -117.6x EV/EBITDA.

Equity research analysts estimate Cuprina Holdings (Cayman)'s 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Cuprina Holdings (Cayman)'s P/E ratio is not available.

See valuation multiples for Cuprina Holdings (Cayman) and 12K+ public comps

Cuprina Holdings (Cayman) Financial Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$168M	XXX	$168M	XXX	XXX	XXX
EV (current)	$168M	XXX	$168M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	3478.0x	XXX	XXX	XXX
EV/EBITDA	n/a	XXX	-117.6x	XXX	XXX	XXX
EV/EBIT	n/a	XXX	-113.4x	XXX	XXX	XXX
EV/Gross Profit	n/a	XXX	n/a	XXX	XXX	XXX
P/E	n/a	XXX	-107.6x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-133.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Cuprina Holdings (Cayman) Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Cuprina Holdings (Cayman) Margins & Growth Rates

Cuprina Holdings (Cayman)'s revenue per employee in the last FY averaged $3K, while opex per employee averaged $0.1M for the same period.

Cuprina Holdings (Cayman)'s rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cuprina Holdings (Cayman)'s rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Cuprina Holdings (Cayman) and other 12K+ public comps

Cuprina Holdings (Cayman) Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	n/a	XXX	n/a	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	-2958%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	n/a	XXX	n/a	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	n/a	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$3K	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	13%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	499%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	3060%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial